1) tumor-specific CTL
肿瘤特异性CTL
1.
The cocultural system in vitro (CCS) was used in the present study to induce tumor-specific CTL by IL-18 in order to investigate the effects of various cell components of peripheral blood to prime and enhance the tumor-specific immune responses.
结果表明 ,在肿瘤抗原存在的条件下 ,CCS中rhIL 18能够诱导并促进CTL介导的肿瘤特异性杀伤效应 ;并且 ,在rhIL 18诱导肿瘤特异性CTL的过程中 ,rhIL 18、NK细胞、DC及T细胞均起着十分重要的作用 ,缺少任一组份 ,均对诱导肿瘤特异性CTL有明显差异 (P <0 0 1)。
2) specific CTL
特异性CTL
1.
The Comparison of inducing specific CTL by two methods of leukemia cell antigen loading of DCs and fusion of DCs with leukemia cells;
两种白血病细胞抗原负载DC的体外诱导特异性CTL应答的比较
2.
Investigaton of the relationship between cytotoxicity of specific CTL and HLA allotype;
特异性CTL胞毒作用与HLA型别关系探讨
3.
HBcAg-specific CTL response induced by PTD-HBcAg fusion protein to inhibit HBV replication in vitro
PTD-HBcAg融合蛋白经树突状细胞诱导特异性CTL抑制HBV的体外研究
3) Specific cytotoxic T lymphocyte
特异性CTL
1.
Induction of specific cytotoxic T lymphocytes and humoral immune response by MUC1 DNA vaccine in mice;
MUC1基因疫苗诱导小鼠特异性CTL和体液免疫应答
5) Anti-tumor cytotoxic T lymphocytes
抗肿瘤CTL
6) PDC-E2 specific CTL
PDC-E2特异性CTL
1.
Functional analysis of HLA-A* 0201-restricted PDC-E2 specific CTLs in primary biliary cirrhosis;
原发性胆汁性肝硬化HLA-A* 0201限制性PDC-E2特异性CTL功能分析
补充资料：肿瘤特异性移植抗原
肿瘤特异性移植抗原
又称肿瘤排斥抗原(tumor rejection antigen，TRA)。宿主对这种抗原有免疫反应，企图通过细胞免疫反应控制肿瘤的生长，或作为异己而排斥。大多数人类肿瘤同一组织类型至少有一种共同的TSTA，而且不与其他类型肿瘤反应，有其肿瘤特异性。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条